Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Diagnostic testing for hepatitis C.

R L Carithers¹, A Marquardt, D R Gretch

¹University of Washington, Seattle 98195-6174, USA. doctorc@u.washington.edu

Seminars in Liver Disease

|August 18, 2000

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The NOX1/4 inhibitor GKT136901 as selective and direct scavenger of peroxynitrite.

Current medicinal chemistry·2013

Same author

Use of the AST to platelet ratio index in HCV/HIV co-infected patients.

Alimentary pharmacology & therapeutics·2011

Same author

Clinical trial: interferon alpha-2b continuous long-term therapy vs. repeated 24-week cycles for re-treating chronic hepatitis C.

Alimentary pharmacology & therapeutics·2007

Same author

Laboratory approaches to the diagnosis of hepatitis C virus infection.

Minerva gastroenterologica e dietologica·2005

Same author

Use and interpretation of HCV diagnostic tests in the clinical setting.

Clinics in liver disease·2004

Same author

The dominant alopecia phenotypes Bareskin, Rex-denuded, and Reduced Coat 2 are caused by mutations in gasdermin 3.

Genomics·2004

Same journal

Endothelial Cell Therapy for the Acute and Chronic Liver Disease.

Seminars in liver disease·2026

Same journal

Neutrophils in Liver Diseases: Functions and Challenging Therapies.

Seminars in liver disease·2026

Same journal

Expert Practical Recommendations for Hepatocellular Carcinoma.

Seminars in liver disease·2026

Same journal

Optimizing Liver Cancer Care Through BCLC Principles.

Seminars in liver disease·2026

Same journal

Patient-Derived Models of Liver Cancer to Inform Clinical Treatment Paradigms: Recent Updates.

Seminars in liver disease·2026

Same journal

Practical Guide to Best Practices in Alcohol-Associated Liver Disease.

Seminars in liver disease·2026

See all related articles

Accurate diagnostic tests for hepatitis C virus (HCV) now screen and confirm infections. Measuring HCV RNA levels and genotype guides treatment, with undetectable RNA marking successful therapy.

Area of Science:

Hepatology
Virology
Clinical Diagnostics

Background:

Diagnostic testing for hepatitis C virus (HCV) has seen significant advancements.
Highly accurate screening and confirmation tests for HCV infection are now accessible.

Purpose of the Study:

To review the advancements in diagnostic tests for hepatitis C virus.
To highlight the utility of HCV RNA levels and genotype in guiding antiviral therapy.
To establish the gold standard for successful HCV treatment.

Main Methods:

Review of diagnostic methodologies for hepatitis C virus.
Analysis of the role of HCV RNA quantification and genotyping in treatment assessment.
Evaluation of PCR-based undetectable HCV RNA as a marker for treatment success.

Related Experiment Videos

Main Results:

Modern diagnostic tests offer high accuracy for screening and confirming hepatitis C.
HCV RNA levels and genotype are crucial for predicting treatment response and optimizing duration.
Absence of detectable HCV RNA via PCR is the established benchmark for successful chronic hepatitis C treatment.

Conclusions:

Selective utilization of advanced hepatitis C diagnostic assays has substantially improved patient care.
Despite costs and limitations, these tests are invaluable in managing chronic hepatitis C.
Undetectable HCV RNA is the definitive indicator of successful antiviral therapy.